Cargando…
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971663/ https://www.ncbi.nlm.nih.gov/pubmed/27484304 http://dx.doi.org/10.1186/s12879-016-1707-8 |
_version_ | 1782446144172851200 |
---|---|
author | Woestenberg, Petra J. Tjhie, Jeroen H. T. de Melker, Hester E. van der Klis, Fiona R. M. van Bergen, Jan E. A. M van der Sande, Marianne A. B. van Benthem, Birgit H. B. |
author_facet | Woestenberg, Petra J. Tjhie, Jeroen H. T. de Melker, Hester E. van der Klis, Fiona R. M. van Bergen, Jan E. A. M van der Sande, Marianne A. B. van Benthem, Birgit H. B. |
author_sort | Woestenberg, Petra J. |
collection | PubMed |
description | BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1 and HSV-2 seroprevalence over time and determinants associated with HSV seropositivity. METHODS: We used data from two population-based seroepidemiological studies conducted in 1995–6 and 2006–7 with a similar study design. Serum samples of 6 months to 44-year-old participants were tested for type-specific HSV antibodies using HerpesSelect® with a cut-off level of >1.10 for seropositivity. Age and sex-specific HSV-1 and HSV-2 seroprevalence was weighted for the Dutch population. Logistic regression was performed to investigate determinants associated with HSV seropositivity. RESULTS: Overall, weighted HSV-1 seroprevalence was significantly lower in 2006–7 [42.7 % 95 % confidence interval (CI) 39.9-45.4] than in 1995–6 (47.7 % 95 % CI 44.8-50.7), especially among 10- to 14-year-olds. Overall, weighted HSV-2 seroprevalence remained stable: 6.8 % in 1995–6 and 6.0 % in 2006–7. Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. CONCLUSIONS: Because of the lower HSV-1 seroprevalence in 2006–7 compared to 1995–6, more adults are susceptible to genital HSV-1, including women of reproductive age. Given the higher risk of neonatal herpes when HSV is acquired during pregnancy, prevention and control measures during pregnancy also targeting HSV-1, are important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1707-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4971663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49716632016-08-11 Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period Woestenberg, Petra J. Tjhie, Jeroen H. T. de Melker, Hester E. van der Klis, Fiona R. M. van Bergen, Jan E. A. M van der Sande, Marianne A. B. van Benthem, Birgit H. B. BMC Infect Dis Research Article BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1 and HSV-2 seroprevalence over time and determinants associated with HSV seropositivity. METHODS: We used data from two population-based seroepidemiological studies conducted in 1995–6 and 2006–7 with a similar study design. Serum samples of 6 months to 44-year-old participants were tested for type-specific HSV antibodies using HerpesSelect® with a cut-off level of >1.10 for seropositivity. Age and sex-specific HSV-1 and HSV-2 seroprevalence was weighted for the Dutch population. Logistic regression was performed to investigate determinants associated with HSV seropositivity. RESULTS: Overall, weighted HSV-1 seroprevalence was significantly lower in 2006–7 [42.7 % 95 % confidence interval (CI) 39.9-45.4] than in 1995–6 (47.7 % 95 % CI 44.8-50.7), especially among 10- to 14-year-olds. Overall, weighted HSV-2 seroprevalence remained stable: 6.8 % in 1995–6 and 6.0 % in 2006–7. Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. CONCLUSIONS: Because of the lower HSV-1 seroprevalence in 2006–7 compared to 1995–6, more adults are susceptible to genital HSV-1, including women of reproductive age. Given the higher risk of neonatal herpes when HSV is acquired during pregnancy, prevention and control measures during pregnancy also targeting HSV-1, are important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1707-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-02 /pmc/articles/PMC4971663/ /pubmed/27484304 http://dx.doi.org/10.1186/s12879-016-1707-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Woestenberg, Petra J. Tjhie, Jeroen H. T. de Melker, Hester E. van der Klis, Fiona R. M. van Bergen, Jan E. A. M van der Sande, Marianne A. B. van Benthem, Birgit H. B. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title_full | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title_fullStr | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title_full_unstemmed | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title_short | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
title_sort | herpes simplex virus type 1 and type 2 in the netherlands: seroprevalence, risk factors and changes during a 12-year period |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971663/ https://www.ncbi.nlm.nih.gov/pubmed/27484304 http://dx.doi.org/10.1186/s12879-016-1707-8 |
work_keys_str_mv | AT woestenbergpetraj herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT tjhiejeroenht herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT demelkerhestere herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT vanderklisfionarm herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT vanbergenjaneam herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT vandersandemarianneab herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod AT vanbenthembirgithb herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod |